Zhejiang Medicine Co., Ltd.
600216.SS
Price:
$13.95
Market Cap:
$13.41B
Zhejiang Medicine Co., Ltd. produces and sells life nutrition and pharmaceutical products in China. The company offers life nutrition products, such as synthetic vitamin E, vitamin A, natural vitamin E, vitamin H, vitamin D3, coenzyme Q10, carotene, cantharidin, lutein, lycopene, and other vitamins and vitamin products. It also provides pharmaceutical manufacturing products, including anti-drug resistant antibiotics, anti-malaria and other pharmaceutical raw materials, quinolones, and anti-drug resistant products; and pharmaceutical products comprising sugars and hormones. The company was founded in 1997 and is headquartered in Shaoxing, China.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1999-10-21
Stock Exchange
SHH
Ticker
600216.SS
PE Ratio
[10.73]
ROE
[11.31%]
Current Ratio
[2.79]
Dividend Yield
[2.65%]
Enterprise Value
[11.52B]
Dividend History
The ROE as of December 2025 (TTM) for Zhejiang Medicine Co., Ltd. (600216.SS) is 11.31%
According to Zhejiang Medicine Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is 11.31%. This represents a change of 299.68% compared to the average of 2.83% of the last 4 quarters.
Zhejiang Medicine Co., Ltd. (600216.SS) Historical ROE (quarterly & annually)
How has 600216.SS ROE performed in the past?
The mean historical ROE of Zhejiang Medicine Co., Ltd. over the last ten years is 6.39%. The current 11.31% ROE has changed 76.91% with respect to the historical average. Over the past ten years (40 quarters), 600216.SS's ROE was at its highest in in the March 2018 quarter at 5.98%. The ROE was at its lowest in in the December 2018 quarter at -1.96%.
Average
6.39%
Median
5.30%
Minimum
2.45%
Maximum
11.91%
Zhejiang Medicine Co., Ltd. (600216.SS) ROE by Quarter and Year
Discovering the peaks and valleys of Zhejiang Medicine Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.92%
Maximum Annual ROE = 11.91%
Minimum Annual Increase = -51.06%
Minimum Annual ROE = 2.45%
| Year | ROE | Change |
|---|---|---|
| 2024 | 10.90% | 144.30% |
| 2023 | 4.46% | -23.44% |
| 2022 | 5.83% | -51.06% |
| 2021 | 11.91% | 27.38% |
| 2020 | 9.35% | 114.37% |
| 2019 | 4.36% | -8.53% |
| 2018 | 4.77% | 37.27% |
| 2017 | 3.47% | -46.16% |
| 2016 | 6.45% | 162.92% |
| 2015 | 2.45% | -5.50% |
Zhejiang Medicine Co., Ltd. (600216.SS) Average ROE
How has 600216.SS ROE performed in the past?
The current ROE of Zhejiang Medicine Co., Ltd. (600216.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.06%
5-year avg
8.49%
10-year avg
6.39%
Zhejiang Medicine Co., Ltd. (600216.SS) ROE vs. Peers
How is 600216.SS’s ROE compared to its peers?
Zhejiang Medicine Co., Ltd.’s ROE is less than Shanghai Shyndec Pharmaceutical Co., Ltd. (6.88%), less than Jiang Zhong Pharmaceutical Co.,Ltd (21.26%), less than Tibet Rhodiola Pharmaceutical Holding Co. (24.95%), less than Xiamen Kingdomway Group Company (11.00%), less than Henan Lingrui Pharmaceutical Co., Ltd. (25.19%), less than Guobang Pharma Ltd. (10.70%), less than Zhejiang Jingxin Pharmaceutical Co., Ltd. (12.52%), less than Zhejiang Hisun Pharmaceutical Co., Ltd. (6.48%), less than Pacific Shuanglin Bio-pharmacy Co., Ltd. (7.03%), greater than CanSino Biologics Inc. (-2.87%),
| Company | ROE | Market cap |
|---|---|---|
| 6.88% | $13.85B | |
| 21.26% | $15.64B | |
| 24.95% | $13.68B | |
| 11.00% | $11.52B | |
| 25.19% | $12.08B | |
| 10.70% | $12.82B | |
| 12.52% | $15.99B | |
| 6.48% | $11.97B | |
| 7.03% | $12.73B | |
| -2.87% | $11.58B |
Build a custom stock screener for Zhejiang Medicine Co., Ltd. (600216.SS) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zhejiang Medicine Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Zhejiang Medicine Co., Ltd. (600216.SS) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Zhejiang Medicine Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Zhejiang Medicine Co., Ltd.'s ROE?
How is the ROE calculated for Zhejiang Medicine Co., Ltd. (600216.SS)?
What is the highest ROE for Zhejiang Medicine Co., Ltd. (600216.SS)?
What is the 3-year average ROE for Zhejiang Medicine Co., Ltd. (600216.SS)?
What is the 5-year average ROE for Zhejiang Medicine Co., Ltd. (600216.SS)?
How does the current ROE for Zhejiang Medicine Co., Ltd. (600216.SS) compare to its historical average?